Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up

Basit Öğe Kaydı
dc.contributor.authorBoz, C.
dc.contributor.authorTerzi, M.
dc.contributor.authorOzakbas, S.
dc.contributor.authorYuceyar, N.
dc.contributor.authorEfendi, H.
dc.contributor.authorBalci, B. P.
dc.contributor.authorTurkoglu, R.
dc.contributor.authorKarabudak, R.
dc.contributor.authorSoysal, A.
dc.contributor.authorYetkin, M. F.
dc.contributor.authorKurne, A.
dc.contributor.authorAkcali, A.
dc.contributor.authorAkman, G.
dc.contributor.authorDemirkiran, M.
dc.contributor.authorSevim, S.
dc.contributor.authorKiyioglu, N.
dc.contributor.authorCilingir, V.
dc.contributor.authorKoseoglu, M.
dc.contributor.authorUzuner, G.
dc.contributor.authorOmerhoca, S.
dc.contributor.authorTuran, O. F.
dc.contributor.authorKizilay, F.
dc.date.accessioned2019-10-27T09:41:20Z
dc.date.available2019-10-27T09:41:20Z
dc.date.issued2019
dc.departmentEge Üniversitesien_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis, Congrex Switzerland Ltden_US
dc.identifier.endpage870en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.startpage870en_US
dc.identifier.urihttps://hdl.handle.net/11454/28611
dc.identifier.volume25en_US
dc.identifier.wosWOS:000485303103364en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleReal world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-upen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu